Schmidt Wolf-Peter, Devamani Carol S, Elangovan Divyaa, Alexander Neal, Rose Winsley, Prakash John A J
Department of Emergency Medicine, Christian Medical College, Vellore, India.
Department for Disease Control, London School of Hygiene and Tropical Medicine, London, UK.
Trop Med Int Health. 2021 Dec;26(12):1616-1623. doi: 10.1111/tmi.13682. Epub 2021 Oct 12.
The clinical and serological characteristics of spotted fever group rickettsial (SFGR) infections in South Asia are poorly understood. We studied the clinical presentation and the IgM/IgG response in cases enrolled at two health care centres in South India.
We enrolled 77 patients. Fifty-seven of these patients were recruited at a tertiary care centre, the remaining 20 at a community hospital (secondary care level). Diagnostic tests included IgM and IgG enzyme-linked immunosorbent assay and polymerase chain reaction. Over a period of 1 year, 41 cases were followed up for repeated sero-analysis.
Median age was 9 years (range 1-79). A rash was present in 74% of cases (57/77). In cases aged <15 years, rash was present in 94% (44/47) vs. 43% (13/30) in cases aged ≥15 years. An eschar was found in two cases (3%). Severe infection or complications occurred in 10 cases (13%). These included central nervous system infection (6/77, 8%), kidney injury (3/77, 4%), shock (3/77, 4%), lung involvement (2/77, 3%) and peripheral gangrene (2/77, 3%). IgM antibody levels increased faster after fever onset than IgG antibodies, peaking at 50 and 60 days, respectively. After the peak, IgM and IgG levels showed a slow decline over one year with less than 50% of cases showing persistent IgG antibody levels.
Spotted fever group rickettsial infections in South India may be under-diagnosed, as many cases may not develop a rash. The proportion of cases developing severe infection seems lower than for scrub typhus in this region. IgG seroprevalence may substantially underestimate the proportion in a population with past SFGR infection.
对南亚斑点热群立克次体(SFGR)感染的临床和血清学特征了解甚少。我们研究了在印度南部两个医疗中心登记的病例的临床表现以及IgM/IgG反应。
我们纳入了77例患者。其中57例患者在三级医疗中心招募,其余20例在社区医院(二级医疗水平)招募。诊断测试包括IgM和IgG酶联免疫吸附测定以及聚合酶链反应。在1年的时间里,对41例病例进行了随访以进行重复血清分析。
中位年龄为9岁(范围1 - 79岁)。74%的病例(57/77)出现皮疹。年龄<15岁的病例中,94%(44/47)出现皮疹,而年龄≥15岁的病例中这一比例为43%(13/30)。发现两例(3%)有焦痂。10例(13%)发生严重感染或并发症。这些包括中枢神经系统感染(6/77,8%)、肾损伤(3/77,4%)、休克(3/77,4%)、肺部受累(2/77,3%)和外周坏疽(2/77,3%)。发热开始后,IgM抗体水平比IgG抗体上升得更快,分别在50天和60天达到峰值。达到峰值后,IgM和IgG水平在1年内缓慢下降,不到50%的病例显示IgG抗体水平持续存在。
印度南部的斑点热群立克次体感染可能诊断不足,因为许多病例可能未出现皮疹。发生严重感染的病例比例似乎低于该地区恙虫病的比例。IgG血清阳性率可能会大幅低估既往有SFGR感染人群中的比例。